United States · 
Who invested in Immune Control?
Immune Control's investors include Domain Associates, NewSpring, BioAdvance and Anthem Capital Management.
United States · Series A startup
Who invested in Immune Control
One round we have observed, with the 4 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$11Mraised across 1 round since 2005, from 1 source
- Latest round
- Series A, $11MJul 2005
- Investors
- 4
The rounds
- Jul 2005Series A$11M
From a historical funding record
The exit
ExitBuyerPriceWhen
AcquiredCorridor PharmaceuticalsundisclosedJun 2010
From historical deal records. Wrong? Tell us.
Everyone who backed them
Anthem Capital ManagementInvestment firm1round
Missing a round, or an investor who was in one? Tell us.
Quick answers about Immune Control
How much has Immune Control raised?
Immune Control has raised $11M across 1 round since 2005.
When did Immune Control last raise?
Immune Control's most recent round was a Series A of $11M in Jul 2005.
What was Immune Control's biggest round?
Its most recent round, $11M in Jul 2005, is also its largest on record.
Who backed Immune Control first?
Immune Control's first round on record, in Jul 2005, was backed by Domain Associates, NewSpring and BioAdvance and 1 others.
What stage is Immune Control at?
Immune Control's latest named round is a Series A, in Jul 2005.
Where is Immune Control based?
Immune Control is based in the United States.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.